Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Butzkueven

Showing results (81-90 of 390) with videos related to

Pageof 39
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 7, 2019
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritisSanuji Gajamange, Jim Stankovich, Gary Egan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2016
Data quality evaluation for observational multiple sclerosis registriesTomas Kalincik, Jens Kuhle, Eugenio Pucci, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 25, 2012
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRIYaou Liu, Yunyun Duan, Peipeng Liang, et al.
Autoimmunity Reviews|April 18, 2026
Innate immunity and biomarkers of multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
Nature Reviews. Neurology|January 14, 2017
Treatment decisions in multiple sclerosis - insights from real-world observational studiesMaria Trojano, Mar Tintore, Xavier Montalban, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2020
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational ProgramHeinz Wiendl, Tim Spelman, Helmut Butzkueven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2014
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme resultsHelmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2023
Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritisSamuel Klistorner, Anneke Van der Walt, Michael H Barnett, et al.
Journal of Neurology|September 24, 2025
The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort studyJason C Ray, Stuart McDonald, Marian Todaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
Re: Genetics of multiple sclerosis severity: The importance of statistical power in replication studies and Re: From discovery to replication: Power and definitions matter for multiple sclerosis severityMaria Pia Campagna, Jeannette Lechner-Scott, Bruce V Taylor, et al.
Pageof 39

Showing results (81-90 of 390) with videos related to

Sort By:
Pageof 39
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 7, 2019
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritisSanuji Gajamange, Jim Stankovich, Gary Egan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2016
Data quality evaluation for observational multiple sclerosis registriesTomas Kalincik, Jens Kuhle, Eugenio Pucci, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 25, 2012
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRIYaou Liu, Yunyun Duan, Peipeng Liang, et al.
Autoimmunity Reviews|April 18, 2026
Innate immunity and biomarkers of multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
Nature Reviews. Neurology|January 14, 2017
Treatment decisions in multiple sclerosis - insights from real-world observational studiesMaria Trojano, Mar Tintore, Xavier Montalban, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2020
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational ProgramHeinz Wiendl, Tim Spelman, Helmut Butzkueven, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2014
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme resultsHelmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2023
Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritisSamuel Klistorner, Anneke Van der Walt, Michael H Barnett, et al.
Journal of Neurology|September 24, 2025
The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort studyJason C Ray, Stuart McDonald, Marian Todaro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
Re: Genetics of multiple sclerosis severity: The importance of statistical power in replication studies and Re: From discovery to replication: Power and definitions matter for multiple sclerosis severityMaria Pia Campagna, Jeannette Lechner-Scott, Bruce V Taylor, et al.
Pageof 39